FDA Approves Baclofen for Spasticity in MS: "Caraco Pharmaceutical Laboratories, Ltd., announced today that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Baclofen Tablets.
Caraco's Baclofen Tablet is a muscle relaxant and antispastic. It is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Caraco has two strengths available, 10 mg and 20 mg tablets....."